Covered recipient · General Payments record
JAMES ESKRIDGE
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Primary Care
General Payments · PY2024
$371.34
- Reported across 17 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $371.34 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $196.11 | 9 |
| Gilead Sciences, Inc. | $74.04 | 3 |
| Novo Nordisk AS | $37.27 | 2 |
| Janssen Pharmaceuticals, Inc | $27.12 | 1 |
| ITI, Inc. | $19.64 | 1 |
| Indivior Inc. | $17.16 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2024 | $371.34 | 17 |
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $31.96 | 06/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107078472 | CMS |
| ABBVIE INC. | $13.22 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107078474 | CMS |
| ABBVIE INC. | $26.02 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107078476 | CMS |
| ABBVIE INC. | $6.65 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107078478 | CMS |
| ABBVIE INC. | $21.93 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107078480 | CMS |
| ABBVIE INC. | $23.75 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107078482 | CMS |
| ABBVIE INC. | $19.81 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107078484 | CMS |
| ABBVIE INC. | $27.03 | 08/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107078486 | CMS |
| ABBVIE INC. | $25.74 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107078488 | CMS |
| Gilead Sciences, Inc. | $21.54 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133704350 | CMS |
| Gilead Sciences, Inc. | $32.46 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133704352 | CMS |
| Gilead Sciences, Inc. | $20.04 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133704354 | CMS |
| Indivior Inc. | $17.16 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144551391 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $19.64 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143441681 | CMS |
| Janssen Pharmaceuticals, Inc | $27.12 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1077940794 | CMS |
| Novo Nordisk Inc | $21.71 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100455756 | CMS |
| Novo Nordisk Inc | $15.56 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100590812 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2024
- Source files
- Dataset page · Bulk file · PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.